1. Global Tuberculosis Report 2022,2022
2. Linezolid-based regimens for multidrug-resistant tuberculosis (TB): a systematic review to establish or revise the current recommended dose for TB treatment;Bolhuis;Clin Infect Dis,2018
3. Nix-TB and ZeNix trials: paving the way for shorter regimens for drug-resistant tuberculosis;Mishra;Asian Pac J Tropical Med,2021
4. Guidelines for Programmatic Management of Drug Resistant Tuberculosis in India 2021 [Internet],2021
5. Ready Reckoner for Medical Officers: Adverse Drug Reactions Associated with Ready Reckoner for Medical Officers, Identification & Management Anti-Tubercular Drugs [Internet],2020